Search results

...iomedical sciences. Areas of interest include gene therapy, cell kinetics, pharmacokinetics, chemotherapy, oncology, developmental biology, wound healing, physiology,

...Celeste C, Vachon P, Marier JF, Plaas AH. "Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinic ...t (i.e. chloride or sulfate) is unlikely to play any role in the action or pharmacokinetics of glucosamine".<ref>[http://www.pdrhealth.com/drug_info/nmdrugprofiles/nut

One of the first thing that hormesis brings to mind is type-0 and type-1 pharmacokinetics, especially drug (or toxin) clearance. Obviously simplified, zero-order kin

...pprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093606.htm Pharmacokinetics in Patients With Impaired Renal Function—Study Design, Data Analysis, and

...nitial stages of treatment of status epilepticus.<ref>Treiman DM. (1989). "Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus

==Pharmacokinetics== Because of warfarin's difficult [[pharmacokinetics]], researchers have proposed algorithms for warfarin loading.

...[bioequivalence|bioequivalent]] to a [[brand]] name drug with respect to [[pharmacokinetics|pharmacokinetic]] and [[pharmacodynamics|pharmacodynamic]] properties. [[Va

...=Heiskanen T, Olkkola KT, Kalso E| title=Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. | journal=Clin Pharmacol Ther | year= 19

...pmid8968655">{{cite journal| author=Davies G, Kingswood C, Street M| title=Pharmacokinetics of opioids in renal dysfunction. | journal=Clin Pharmacokinet | year= 1996 ...nd metabolized by [[cytochrome P-450 CYP2D6]] which may lead to variable [[pharmacokinetics]] due to [[single-nucleotide polymorphism]]s and [[drug interaction]]s.<ref

== Misplaced in the pharmacokinetics debate ==

...cite journal |author=Zineh I, Beitelshees AL, Gaedigk A, ''et al.'' |title=Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy i

...="pmid8623000">{{cite journal |author=Levine M ''et al.'' |title=Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance |journa === Based on pharmacokinetics ===

* [[Pharmacokinetics]]

As noted above (see '''Therapeutic uses, Cancer'''), the study of vitamin C [[pharmacokinetics]] not only triggered changes in the recommended dietary allowance of this v

...penetration of one or both fangs from the snake, amount of venom injected, pharmacokinetics of the venom, location of the bite, and proximity to major blood vessels. T

...w-resolution approaches. Improved information of drug logistics and target pharmacokinetics enables effective drug selection, dose determination and prediction. It als

...w-resolution approaches. Improved information of drug logistics and target pharmacokinetics enables effective drug selection, dose determination and prediction. It als

...a part, I believe, of the broader disciplines of dose-response studies and pharmacokinetics. There are totally non-homeopathic situations in which issues that could be

...bp.org/fileadmin/pdf/world-journal-public/Vol%203-1.pdf}}, page 17, "2.1.8 Pharmacokinetics and pharmacogenetics of antidepressants"</ref> In others, a patient and her